Vivos Inc (RDGL) stock
RDGLOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.05−0.00 (-2.51%)
Close on Oct 19, 2026Market cap $23.44MP/E –Yield –
Vivos operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Vivos's operating cash flow for the twelve months ending Jun 30, 2026 was -$2.17M. For fiscal 2025 it was -$2.06M. The highest annual figure on record is -$700.45K in fiscal 2018.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$2.06M | – |
| FY2024 | Dec 31, 2024 | -$1.68M | – |
| FY2023 | Dec 31, 2023 | -$1.29M | – |
| FY2022 | Dec 31, 2022 | -$1.12M | – |
| FY2021 | Dec 31, 2021 | -$963.82K | – |
| FY2020 | Dec 31, 2020 | -$875.81K | – |
| FY2019 | Dec 31, 2019 | -$837.11K | – |
| FY2018 | Dec 31, 2018 | -$700.45K | – |
| FY2017 | Dec 31, 2017 | -$1.29M | – |
| FY2016 | Dec 31, 2016 | -$1.93M | – |
| FY2015 | Dec 31, 2015 | -$1.19M | – |
| FY2014 | Dec 31, 2014 | -$1.14M | – |
| FY2013 | Dec 31, 2013 | -$2.04M | – |
| FY2012 | Dec 31, 2012 | -$1.80M | – |
| FY2011 | Dec 31, 2011 | -$858.84K | – |
| FY2010 | Dec 31, 2010 | -$2.45M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$739.58K | – |
| Q1 FY2026 | Mar 31, 2026 | -$429.86K | – |
| Q4 FY2025 | Dec 31, 2025 | -$539.55K | – |
| Q3 FY2025 | Sep 30, 2025 | -$458.48K | – |
| Q2 FY2025 | Jun 30, 2025 | -$604.51K | – |
| Q1 FY2025 | Mar 31, 2025 | -$455.20K | – |
| Q4 FY2024 | Dec 31, 2024 | -$470.91K | – |
| Q3 FY2024 | Sep 30, 2024 | -$506.26K | – |
| Q2 FY2024 | Jun 30, 2024 | -$355.41K | – |
| Q1 FY2024 | Mar 31, 2024 | -$351.46K | – |
| Q4 FY2023 | Dec 31, 2023 | -$463.14K | – |
| Q3 FY2023 | Sep 30, 2023 | -$221.92K | – |
| Q2 FY2023 | Jun 30, 2023 | -$314.34K | – |
| Q1 FY2023 | Mar 31, 2023 | -$293.63K | – |
| Q4 FY2022 | Dec 31, 2022 | -$281.67K | – |
| Q3 FY2022 | Sep 30, 2022 | -$282.97K | – |
| Q2 FY2022 | Jun 30, 2022 | -$171.12K | – |
| Q1 FY2022 | Mar 31, 2022 | -$384.30K | – |
| Q4 FY2021 | Dec 31, 2021 | -$235.47K | – |
| Q3 FY2021 | Sep 30, 2021 | -$178.08K | – |
| Q2 FY2021 | Jun 30, 2021 | -$347.18K | – |
| Q1 FY2021 | Mar 31, 2021 | -$203.10K | – |
| Q4 FY2020 | Dec 31, 2020 | -$365.58K | – |
| Q3 FY2020 | Sep 30, 2020 | -$183.92K | – |
| Q2 FY2020 | Jun 30, 2020 | -$239.06K | – |
| Q1 FY2020 | Mar 31, 2020 | -$87.25K | – |
| Q4 FY2019 | Dec 31, 2019 | -$253.16K | – |
| Q3 FY2019 | Sep 30, 2019 | -$184.96K | – |
| Q2 FY2019 | Jun 30, 2019 | -$127.29K | – |
| Q1 FY2019 | Mar 31, 2019 | -$271.71K | – |
| Q4 FY2018 | Dec 31, 2018 | -$532.65K | – |
| Q3 FY2018 | Sep 30, 2018 | -$70.93K | – |
| Q2 FY2018 | Jun 30, 2018 | -$48.58K | – |
| Q1 FY2018 | Mar 31, 2018 | -$48.30K | – |
| Q4 FY2017 | Dec 31, 2017 | -$163.79K | – |
| Q3 FY2017 | Sep 30, 2017 | -$347.34K | -111.1% |
| Q2 FY2017 | Jun 30, 2017 | -$501.29K | – |
| Q1 FY2017 | Mar 31, 2017 | -$275.66K | – |
| Q4 FY2016 | Dec 31, 2016 | -$3.57M | – |
| Q3 FY2016 | Sep 30, 2016 | $3.13M | – |
See a number that looks wrong?